Search results
Is This Monster Stock on the Verge of a Home Run?
Motley Fool· 2 years agoLate last month, AstraZeneca's (NASDAQ: AZN) rare disease drug called Ultomiris received the green light from the European Commission to treat adult...
These Inhalers No Longer Cost More Than $35 Per Month
Verywell Health via Yahoo News· 2 months agoGrace Cary / Getty Images Fact checked by Nick Blackmer Key Takeaways Three major pharmaceutical...
Pennsylvania woman stunned to be charged $50K for asthma medication. No one can explain it
USA TODAY via Yahoo News· 2 years agoYORK, Pa. — Jessica Eckard has always had asthma problems. Her father died of tuberculosis when she...
Pfizer (PFE) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoPfizer PFE will report second-quarter 2022 results on Jul 28, before market open. In the last...
What This News Means for Merck
Motley Fool· 2 years agoIn combination with Roche's (OTC: RHHBY) bevacizumab (Avastin), Merck's (NYSE: MRK) oncology medicine -- co-owned with AstraZeneca (NASDAQ: AZN) and...
Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
Zacks via Yahoo Finance· 2 months agoSanofi SNY reported first-quarter 2024 adjusted earnings of 96 cents per American depositary share,...
Biotech Stock Roundup: REGN Down on Eylea Data, CINC Surges on AZN Offer & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, Regeneron...
Sanders, Democrats launch investigation into asthma inhaler pricing
The Hill via Yahoo News· 5 months agoSen. Bernie Sanders (I-Vt.) and a group of Senate Democrats on Monday announced an investigation...
Cancer Is Capsizing Americans’ Finances. ‘I Was Losing Everything.’
The Wall Street Journal· 2 weeks agoHEALTH NEWS Gwendolyn Jackson was financially sound before her cervical cancer diagnosis—she was...
Pieris (PIRS) Pursues Strategic Alternatives, Stock Rises
Zacks via Yahoo Finance· 11 months agoPieris Pharmaceuticals’ PIRS shares were up almost 12% on Jul 18, after management announced...